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INTRODUCTION
Exercise is a common stimulus for asthma symptoms in asth-
matic patients. The prevalence of exercise-induced asthma (EIA) 
in asthmatic patients has been reported to be 40%-90%.
1 This 
wide variation may result from many factors, including the se-
verity of the underlying airway hyperresponsiveness (AHR) in 
enrolled patients and environmental factors such as cold air. Our 
previous studies have shown that the maximal fall in forced ex-
piratory volume in one second (FEV1) after exercise (exercise-
induced bronchoconstriction, EIB) is significantly related to 
methacholine-AHR
2,3 and 4.5% hypertonic saline-AHR,
2 and 
that the prevalence of EIA in patients with perennial asthma is 
significantly related to temperature and humidity (prevalence 
of 50.0% in summer, 86.4% in spring/fall, and 84.0% in winter).
4
More than 80% of asthma cases occur through Th2 immune 
reactions after exposure to allergens such as house dust mites 
(HDMs) in subjects with allergic diathesis.
5 The HDMs Derma-
tophagoides farinae (D. farinae) and D. pteronyssinus are the 
most common allergens,
6 and sensitization to HDMs is signifi-
cantly related to AHR.
7 Sears et al.
8 reported that the relative risk 
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for AHR is 4.45 times higher in children sensitized to HDMs. 
Pollen allergy is more significantly related to allergic rhinitis 
than to asthma.
9 In our previous study, we also found that the 
relative risk for moderate or severe methacholine-AHR was 1.21 
times higher in subjects sensitized to D. farinae and 0.72 times 
higher in subjects sensitized to hazel pollen than in non-sensi-
tized subjects.
6
Concentrations of indoor HDMs and pollen show seasonal 
variation,
10,11 while the incidence of AHR varies seasonally de-
pending on the concentration of HDMs.
10 The prevalence of 
EIA may therefore also differ between seasons not only under 
the direct influence of temperature and humidity, but also un-
der the indirect influence of concentrations of allergens, which 
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Purpose:  Exercise-induced bronchoconstriction (EIB) in patients with asthma occurs more frequently in winter than in summer. The concentration 
of house dust mite (HDM) allergens in beds also shows seasonal variation. This study examined the relationship between seasonal differences in 
the prevalence of EIB and sensitization to HDMs in patients with asthma.  Methods:  The medical records of 74 young adult male patients with 
asthma-like symptoms who underwent bronchial challenge with methacholine, 4.5% saline and exercise, and allergen skin prick tests, were reviewed. 
The subjects were divided into summer (n=27), spring/fall (n=26) and winter (n=21) groups according to the season during which they underwent 
testing.  Results:  The positive responses to exercise differed according to season (48.1% in summer, 73.1% in spring/fall, and 90.5% in winter; P<
0.01). In addition, the prevalence of positive responses to HDM (70.4%, 88.5%, and 95.2%, respectively; P<0.05) and pollen skin tests (37.0%, 19.2%, 
and 0%, respectively; P<0.01) also showed significant seasonal differences. Severe responses to 4.5% saline showed a similar trend, although it 
was not statistically significant (44.4%, 50.0%, and 71.4%, respectively; P=0.07). Skin test reactivity to HDMs was significantly related to maximal 
fall in forced expiratory volume in one second (FEV1) following exercise (r=0.302, P<0.01) and the index of airway hyperresponsiveness (AHR) to 
4.5% saline (r=-0.232, P<0.05), but not methacholine (r=-0.125, P>0.05).  Conclusions:  Positive skin test reactions to HDMs and EIB occurred 
in winter, spring/fall, and summer in decreasing order of frequency. Seasonal variation in the prevalence of EIB may be related to seasonal variation 
in sensitization to HDMs, accompanied by differences in indirect, but not direct, AHR.
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change in association with changes in temperature and humid-
ity. Although it has been demonstrated that EIA is aggravated 
during pollen seasons in patients with pollen allergy,
12,13 no 
study, as far as we know, has examined whether EIA is aggra-
vated seasonally when sensitization to HDMs is increased in 
patients with asthma. Thus, this study was conducted to exam-
ine the relationship between seasonal differences in the preva-
lence of EIA and sensitization to HDMs in asthmatics.
MATERIALS AND METHODS
Subjects
Young male subjects with asthma-like symptoms aged 18-30 
years who visited the Department of Allergy, Chonnam Nation-
al University Hospital in order to obtain a medical certificate 
that granted them exemption from military service between 
January 2004 and February 2009 were enrolled into this study. 
From their charts, we retrospectively collected information 
about patient age, height, duration of asthma, and the results of 
skin prick tests, and bronchial challenge with methacholine, 
4.5% hypertonic saline, or exercise. Subjects who underwent all 
of the three aforementioned bronchial challenge tests were in-
cluded in the study. The subjects were divided into summer 
(June to September, n=27), spring/fall (March to May/October 
to November, n=26) and winter (December to February, n=21) 
groups according to the seasons during which they underwent 
the tests.
Bronchial challenge tests
Bronchial challenge tests were performed according to our 
protocol. Exercise challenges were performed first, 4.5% hyper-
tonic saline tests on the next day, and methacholine-AHR tests 
at least 4 hours after the hypertonic saline tests. The following 
medications were withdrawn before the tests: anti-histamines 
(from at least 48 hours before the tests), theophylline (24 
hours), long-acting β2 agonists (24 hours), ipratropium (12 
hours), and short-acting β2 agonists (8 hours). Pulmonary func-
tion tests were conducted using a Spiro-Analyzer ST-250 com-
puterized spirometer (Fukuda Sangyo, Tokyo, Japan). The rep-
resentative values for spirometry were selected from the “best 
spirogram”-the one for which the sum of forced vital capacity 
(FVC) and FEV1 was largest among the three or more accept-
able spirograms-according to the method proposed by the In-
termountain Thoracic Society.
14 Regression equations provided 
by Crapo et al.
15 were used for reference spirometric values.
Exercise challenges
Exercise challenges were performed using the free running 
method described in a previous study.
4 Exercise intensity was 
increased during the first 2-3 minutes until the heart rate (HR) 
reached 85% of the maximal rate (220 minus the subject age), 
and this HR was maintained for up to 6 minutes after the start 
of the exercise. FEV1 was measured before exercise and 1, 3, 5, 
7, 10, 15, 20, 30, 45, and 60 minutes after exercise (three times 
per time point). The highest value at each time point was re-
garded to be representative. EIB was calculated using the fol-
lowing equation: EIB=(pre-exercise FEV1 value - post-exercise 
lowest FEV1 value)/pre-exercise FEV1 value×100. EIA was de-
fined as an EIB of ≥15%. By modifying the EIA severity assess-
ment method of Lazo-Velásquez et al.,
16 which uses peak expi-
ratory flow, we rated EIB on a 4-point scale:<15%, 0 points 
(normal); 15%-25%, 1 point (mild); 25%-50%, 2 points (moder-
ate); and ≥50%, 3 points (severe).
Hypertonic saline challenge tests
Hypertonic saline challenge tests were performed according 
to the method proposed by Iredale et al.
17 The subjects inhaled 
4.5% hypertonic saline aerosols generated using an Ultra-neb 
200 ultrasonic nebulizer (DeVilbiss Co, Somerset, PA; output 
0.15 mL/min) through a mouthpiece with the nose clipped, for 
inhalation periods that doubled successively in length (0.5, 1, 2, 
4, and 8 minutes). FEV1 was measured 30 and 90 seconds after 
each inhalation period. The test proceeded to the next step 
within 3 minutes of the end of the previous inhalation period. If 
FEV1 decreased by <10%, the inhalation time was doubled; if 
FEV1 decreased by 10%-15%, the inhalation time was main-
tained; if FEV1 decreased by ≥15% or the maximal volume of 
saline was inhaled, inhalation was stopped. A dose-response 
curve was constructed by plotting % decrease in FEV1 against 
the logarithm of the cumulative volume of aerosol delivered (in 
mL) for each inhalation period. The provocative dose of hyper-
tonic saline that induced a 15% fall of FEV1 (PD15) was calcu-
lated by linearly interpolating from the log-dose-response curve. 
For subjects who did not respond to the maximal saline dose, 
the provocation dose was assigned a value by doubling the 
maximal dose inhaled. By modifying the method of Anderson 
and Brannan,
18 we defined a positive response to the test as a 
PD15 value of ≤20 mL (instead of maximal dose), and rated 
the degree of airway responsiveness to hypertonic saline on a 
4-point scale: >20 mL, 0 points (normal); 6-20 mL, 1 point (mild); 
2-6 mL, 2 points (moderate); and <2 mL, 3 points (severe).
Methacholine provocation tests
Methacholine-AHR tests were performed using the tidal 
breathing method standardized by Cockcroft.
19 Fresh metha-
choline solutions with concentrations of 0.075, 0.15, 0.31, 1.25, 
2.5, 5.0, 10, and 25 mg/mL were prepared every morning of the 
study. Aerosols generated using a DeVilbiss 646 jet nebulizer 
(DeVilbiss Co; output 0.13 mL/min) were inhaled by tidal 
breathing for 2 minutes at 5-minute intervals. When the FEV1 
value decreased by ≥20% as compared with the post-saline 
control value, methacholine inhalation was stopped. The con-
centration that reduced the FEV1 value by 20% (PC20, mg/mL) 
was obtained by linear interpolation from the log dose-response Choi et al.
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curve. If FEV1 did not decrease by ≥20% at a concentration of 
25 mg/mL, the PC20 value was regarded to be 50 mg/mL. The 
method of Woolcock and Jenkins
20 for classifying the severity of 
methacholine-AHR was modified with reference to the classifi-
cation by Cockcroft,
21 and severity was rated on a 4-point scale: 
PC20>16 mg/mL, 0 points (normal); 2-16 mL, 1 point (mild); 
0.2-2 mL, 2 points (moderate); and <0.2 mL, 3 points (severe).
Skin prick tests
Skin pick tests were performed with eight common allergens, 
including HDMs (D. farinae and D. pteronyssinus), cat, dog, 
mold (Aspergillus fumigatus), tree pollen (hazel), grass pollen 
(timothy), and weed pollen (ragweed). A histamine solution (1 
mg/mL) was used as a positive control and normal saline as a 
negative control. Wheal and flare sizes were measured 15 min-
utes after the application of test allergens. The largest and small-
est diameters of wheals at right angles to each other were 
summed and divided by 2. Skin test positivity was assessed by 
calculating the ratio of the size of the wheal induced by the al-
lergen to the size of the wheal induced by histamine solution. 
Size ratios were classified as follows: 25%-50%, 1+; 50%-99%, 
2+; 100%-199%, 3+; and ≥200%, 4+. The atopy score was de-
fined as the sum of the degrees of positivity (maximum, 32).
22 
Reactions with scores of ≥3+ were deemed to indicate clinical-
ly significant allergy.
23
Statistical analysis
Data are presented as the mean±standard error. Statistical 
analyses were performed using SPSS for Windows version 18.0 
(SPSS Inc., Chicago, IL, USA). Statistical comparisons were made 
using the chi-square test for trends, the Kruskal-Wallis test, the 
Mann-Whitney U test, and logistic regression. Correlations be-
tween variables were assessed using Spearman rank correla-
tion coefficients. A P value of <0.05 was considered statistically 
significant.
RESULTS
There was no significant difference in age or atopy score be-
tween the different season groups (Table 1). However, the dura-
tion of asthma was significantly longer in the summer and win-
ter groups than the spring/fall group, and the proportion of 
subjects with peripheral blood eosinophil counts≥5% was 
higher in the summer group. In addition, the rate of positive re-
sults for skin tests with HDMs progressively increased, and for 
tests with pollen progressively decreased, from summer and 
spring/fall to winter.
There was no significant difference in baseline lung function 
or methacholine-AHR between the different seasons (Table 1). 
However, the prevalence of severe hypertonic saline-AHR tend-
ed to be higher during low-temperature seasons, although not 
significantly so (44.4% in summer, 50.0% in spring/fall and 
71.4% in winter; χ2=3.3, P=0.071; Figure). Moreover, EIB was 
significantly larger in spring/fall and winter than in summer, 
and so the prevalence of EIA was lowest in summer and highest 
in winter (Table 1; Figure). When the severity of AHR was com-
pared among the different measurement methods, moderate 
methacholine-AHR and moderate EIB were similar to severe 
hypertonic saline-AHR.
EIB showed a direct correlation with skin test reactivity to 
HDMs and atopy score, but an inverse correlation with the 
FEV1/FVC ratio, methacholine-AHR, and hypertonic saline-
AHR (Table 2). Methacholine-AHR and hypertonic saline-AHR 
were correlated with the duration of asthma, blood eosinophil 
count, FEV1, atopy score, and FEV1/FVC ratio. Hypertonic sa-
line-AHR, but not methacholine-AHR, was significantly corre-
lated with skin reactivity to HDMs.
Season, duration of asthma, FEV1/FVC ratio, methacholine-
AHR, and hypertonic saline-AHR showed significant relative 
risks for moderate or severe EIB (Table 3). The crude odds ra-
tios (ORs) for moderate or severe EIB were 22.2 in moderate or 
severe methacholine-AHR and 5.8 in severe hypertonic saline-
AHR. In a multivariate logistic regression analysis, the adjusted 
OR for moderate or severe EIB was 19.28 (95% confidence in-
Table 1.  Clinical characteristics of young male patients with asthma in the 
summer, spring/fall, and winter groups, and bronchoprovocation test results
Summer 
(n=27)
Spring/Fall 
(n=26)
Winter 
(n=21)
Age, years 21.0±0.3 21.0±0.5 22.3±0.7
Duration of asthma, years 8.1±1.0 4.6±0.9
‡ 9.0±1.2
II
Blood eosinophil count≥5%* 53.8% 23.1% 28.6%
SPT reactivity to HDMs≥3+* 70.4% 88.5% 95.2%
SPT reactivity to pollen≥3+
† 37.0% 19.2% 0%
Atopy score 9.7±1.2 10.1±1.1 9.1±0.6
FEV1, % predicted 85.5±2.2 84.7±2.5 85.6±2.5
FEV1/FVC, % 83.1±1.4 81.6±1.7 80.1±1.5
Methacholine PC20 (geometric 
mean, mg/mL)
1.54 1.64 0.87
Methacholine PC20≤16 mg/mL 77.8% 76.9% 90.5%
4.5% saline PD15, mL 7.6±2.9 7.7±2.7 4.4±2.3
4.5% saline PD15≤20 mL  88.9% 92.3% 95.2%
Maximal FEV1 fall after exercise, % 16.6±2.3 28.9±4.0
‡ 38.4±4.5
§
Maximal FEV1 fall≥15%
† 48.1% 73.1% 90.5%
SPT reactivity ≥3+: ≥100% allergen/histamine wheal size ratio in skin prick 
test.
HDMs, house dust mites: D. farinae and D. pteronyssinus.
Pollen: hazel, timothy and ragweed.
Atopy score: sum of skin prick test grades for two HDMs, three types of pollen, 
cat, dog, and A. fumigatus.
FEV1, forced expiratory volume in one second; FVC, forced vital capacity; PC20, 
provocative concentration of methacholine causing a 20% fall in FEV1; PD15, 
cumulative provocative dose of 4.5% saline causing a 15% fall in FEV1.
*P<0.05, 
†P<0.01 (chi-square test); 
‡P<0.05, 
§P<0.001 vs. summer; 
IIP<0.01 
vs. spring/fall.EIA-Influencing Seasonal Factors
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terval [CI]=3.06-121.51, P=0.002) in season and 38.40 (6.17-
239.22, P=0.000) in moderate or severe methacholine-AHR.
DISCUSSION
In this study, the prevalence of EIA among young male pa-
tients with asthma-like symptoms was 48.1% in summer, 73.1% 
in spring/fall, and 90.5% in winter, suggesting significant sea-
sonal variation. In our previous study, the prevalence of EIA 
was 50.0% in summer, 86.4% in spring/fall, and 84.0% in win-
ter.
4 These results may be explained by the fact that there are 
considerable seasonal differences in mean temperature (25.3°C 
in summer, 16.1°C in fall, 11.0°C in spring, and 3.5°C in winter) 
and humidity (74.6% in summer, 69.1% in fall, 57.7% in spring, 
and 66.2% in winter) in Korea.
4 In the previous and present 
studies, exercise challenges were performed using the free run-
ning method. The test results were therefore directly affected by 
temperature and humidity. These results represent the actual 
clinical setting, as the free running was performed outdoors, 
and it is possible that the seasonal variation in EIA may not be 
easily observed when exercise challenges are performed in-
doors with a treadmill or a bicycle.
In addition, the results of this study indicate that the seasonal 
variation in EIA prevalence may also be affected by seasonal 
variation in the rate of sensitization to allergens and the severity 
of AHR. The rate of clinically significant sensitization (≥3+) to 
HDMs (70.4% in summer, 88.5% in spring/fall, and 95.2% in 
winter) and pollen (37.0%, 19.2%, and 0%, respectively) varied 
seasonally. Based on our findings that both the rate of sensiti-
zation to HDMs and prevalence of EIA were low in summer and 
high in winter, and that there was a significant correlation be-
tween the severity of EIB and skin reactivity to HDMs, it is con-
ceivable that sensitization to HDMs may have a significant ef-
fect on the prevalence of EIA. Because sensitization to HDMs is 
significantly correlated with AHR,
7 and because subjects sensi-
tized to HDMs have a higher risk of AHR,
6,8 AHR associated with 
sensitization to HDMs would easily lead to EIB. The rate of sen-
sitization to pollen is naturally low in winter, and pollen allergy 
is more closely related to allergic rhinitis than to asthma,
9 al-
though EIA can be aggravated during pollen seasons in patients 
Table 2.  Relationship between airway responses to various stimuli and other 
variables in asthma
Methacholine 4.5% saline Exercise
Asthma duration -0.267* -0.363
† 0.199
Blood eosinophil -0.392
† -0.420
‡ 0.094
Skin reactivity to HDMs -0.125 -0.232* 0.302
†
Skin reactivity to pollen 0.005 -0.188 -0.017
Atopy score -0.239* -0.410
‡ 0.229*
FEV1, % predicted 0.285* 0.318
† -0.074
FEV1/FVC 0.396
† 0.460
‡ -0.328
†
4.5% saline 0.741
‡ - -0.515
‡
Exercise -0.536
‡ -0.515
‡ -
HDMs, house dust mites: D. farinae and D. pteronyssinus.
Pollen: hazel, timothy, and ragweed.
Atopy score: sum of skin prick test grades for two HDMs, three types of pollen, 
cat, dog, and A. fumigatus.
FEV1, forced expiratory volume in one second; FVC, forced vital capacity.
*P<0.05, 
†P<0.01, 
‡P<0.001.
Table 3.  Relative risk for moderate to severe exercise-induced asthma
Crude OR  95% CI P value
Season 7.000 1.940-25.255 0.003
Duration of asthma, years 1.101 1.003-1.208 0.044
Blood eosinophil count≥5% 1.263 0.481-3.320 0.636
Skin test reactivity to HDMs 1.185 0.983-1.427 0.074
Skin test reactivity to pollen 1.042 0.838-1.295 0.713
Atopy score 1.098 0.997-1.208 0.056
FEV1/FVC, % 0.915 0.855-0.981 0.012
Methacholine PC20 (mg/mL) 0.158 0.062-0.402 0.000
Methacholine PC20≤2 mg/mL 22.176 4.670-105.308 0.000
4.5% saline PD15, mL 0.796 0.652-0.971 0.025
4.5% saline PD15≤2 mL  5.786 2.036-16.445 0.001
OR, odds ratio; CI, confidence interval.
HDMs, house dust mites: D. farinae and D. pteronyssinus.
Pollen: hazel, timothy, and ragweed.
Atopy score: sum of skin prick test grades for two HDMs, three types of pollen, 
cat, dog, and A. fumigatus.
FEV1, forced expiratory volume in one second; FVC, forced vital capacity; PC20, 
provocative concentration of methacholine causing a 20% fall in FEV1; PD15, 
cumulative provocative dose of 4.5% saline causing a 15% fall in FEV1.
Figure.  Comparisons of the distribution of subjects with varying degrees of 
airway responsiveness to methacholine and 4.5% hypertonic saline aerosols, 
and exercise challenges across different seasons. Mild/moderate/severe: 
methacholine PC20, 2-16/0.2-2/<0.2 mg/mL; 4.5% saline-PD15, 6-20/2-6/<2 
mL; % fall in FEV1 after exercise, 15-25/25-50/>50%.
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with asthma who are sensitized to pollen.
12,13 Therefore, our pa-
tients that were sensitized to pollen seemed to show an inverse 
correlation with EIA, unlike those sensitized to HDMs. The rel-
ative risk of AHR was 0.72 times higher in patients sensitized to 
hazel pollen in our previous study.
6
Methacholine-AHR and 4.5% hypertonic saline-AHR did not 
show statistically significant seasonal variation, as shown in our 
previous study.
4 However, the geometric mean methacholine 
PC20 value tended to be lower in winter (0.87 mg/mL in winter, 
1.54 mg/mL in summer, and 1.64 mg/mL in spring/fall), and 
hypertonic saline-AHR tended to be more severe in winter 
(71.4% in winter, 44.4% in summer, and 50.0% in spring/fall). 
Based on our findings that EIB was significantly correlated with 
methacholine-AHR and hypertonic saline-AHR, and that the 
relative risk of moderate or severe EIB was 22 times higher in 
patients with moderate or severe methacholine-AHR and 5.8 
times higher in those with severe hypertonic saline-AHR, we 
conclude that seasonal variation in AHR may affect seasonal 
variation in the prevalence of EIA.
Although seasonal variation in methacholine-AHR was mini-
mal, the variation in hypertonic saline-AHR showed a similar 
trend to that for EIA in this study. Methacholine acts directly on 
receptors in airway smooth muscles. Thus, methacholine-AHR 
can occur in patients with respiratory diseases other than asth-
ma.
24 However, exercise and hypertonic saline act through 
chemical mediators released by inflammatory cells or sensory 
nerve stimulation, and the test results obtained using these in-
direct stimuli are more specific for asthma.
25 Moreover, since 
changes in the osmotic pressure of airway lining fluid is an im-
portant and common mechanism of EIA and hypertonic saline-
AHR,
26 the EIB and hypertonic saline-AHR results may be more 
closely related, and hypertonic saline-AHR may well reflect sea-
sonal variation, similar to EIB. Asthma is an inflammatory air-
way disease that occurs after exposure to offending allergens, 
and it is associated with irreversible structural changes (airway 
remodeling) as a result of an aberrant repair process. While air-
way inflammation is associated with variable or inducible AHR 
that can be improved by inhaled steroids, airway remodeling 
induces permanent AHR that cannot be improved with medi-
cal treatment.
27 Methacholine-AHR is associated with both 
variable AHR and permanent AHR, whereas EIA and hyperton-
ic saline-AHR are mainly associated with variable AHR.
3,27 There-
fore, although hypertonic saline-AHR and EIB sensitively repre-
sent seasonal variation in sensitization to HDMs, associated 
airway inflammation, and variable AHR, methacholine-AHR 
may not properly reflect slight seasonal variation in variable 
AHR because of preexisting permanent AHR. These findings 
are consistent with the results of a previous study showing that 
hypertonic saline-AHR is more closely related to the number of 
eosinophils, interleukin (IL)-5 concentration, and the interferon-
γ:IL-5 ratio in sputum than to methacholine-AHR.
28 Further, 
these results are also consistent with a longitudinal study show-
ing that changes in EIB over time are larger than those in metha-
choline-AHR.
3
Despite the definition of positive hypertonic saline-AHR with 
a fall in FEV1 of ≥15% being restricted to ≤20 mL in this study, 
rather than the maximal provocation dose of saline proposed 
by Anderson and Brannan,
18 positive reactions to hypertonic 
saline occurred more frequently than reactions to methacho-
line or exercise. In addition, severe hypertonic saline-AHR had 
a prevalence similar to that of moderate methacholine-AHR 
and moderate EIB. When the hypertonic saline-AHR test was 
first introduced into clinical practice, a positive reaction was 
defined as a fall in FEV1 of ≥20%. However, this definition has 
since been changed to a fall in FEV1 of ≥15% based on data 
from numerous healthy subjects.
29 Moreover, review articles by 
Anderson and Gibson
30 in 1997 and Anderson and Brannan
18 
in 2003 used PD15 to classify the severity of AHR; therefore, we 
used PD15 in the present study. However, considering the high 
rate of hypertonic saline-AHR, further studies on PD20 and 
more strictly defined criteria for the severity of AHR are needed 
to accurately interpret test results obtained using hypertonic sa-
line.
The indoor concentration of HDMs is closely related to hu-
midity, and the number of HDMs increases in summer and 
progressively decreases thereafter; however, the concentration 
of group 1 mite allergens is maintained until winter.
31 In Korea, 
the concentration of Der f 1 increases in summer and is main-
tained until winter. Serum Der f 1-specific antibody levels are 
high in inhabitants with high Der f 1 levels in their bedclothes 
dust.
32 HDM concentrations
32 and HDM-specific antibody lev-
els
33 are highest in autumn. Patients sensitized to HDMs have 
severe methacholine-AHR.
34 With increasing concentrations of 
Der p 1, histamine-AHR becomes more severe,
10 and severe 
asthma attacks occur more frequently.
33 However, the rate of 
sensitization to HDMs was highest in winter in the present study. 
Since we only assessed subjects with asthma who wanted to 
obtain a medical certificate granting them exemption from mil-
itary service, it is possible that their symptoms were aggravated 
in the fall, but that they were not admitted to the hospital until 
winter due to long waiting times. For this reason, our results ap-
peared to differ from those of previous studies. Further studies 
on this issue are therefore warranted. The number of peripheral 
blood eosinophils was previously found to be closely related to 
AHR.
35 Similarly, our study showed that there was a significant 
correlation between the number of eosinophils and methacho-
line-AHR/hypertonic saline-AHR. However, since the sensitiza-
tion rate to pollen and the number of eosinophils increased in 
summer, the relationship between eosinophilia and EIA that 
usually occurs in other seasons became insignificant in this 
study.
Hypertonic saline-AHR, which occurs through a similar mech-
anism to EIB, but was examined indoors in contrast to the free-
running test for EIB, showed only a non-significant trend toward EIA-Influencing Seasonal Factors
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increased prevalence during low-temperature seasons, while 
EIB showed an apparent increase in prevalence. Thus, outdoor 
cold air and humidity would play roles as confounding factors 
in the EIB test and the actual influence of sensitization to HDMs 
on EIB would be limited. Further study of EIB using a treadmill 
or a bicycle indoors is required to exclude the effects of cold air 
and humidity. Other limitations of this study were the small 
numbers of subjects and the fact that the study group was limit-
ed to young men. Further studies are necessary to address these 
limitations.
In summary, EIB occurred most frequently in winter, followed 
by spring/fall and summer. Skin reactivity to HDMs and pollen 
also showed seasonal variation. Methacholine-AHR did not 
show significant seasonal variation, but hypertonic saline-AHR 
showed similar variation to EIB. The results of this study sug-
gest that the change in hypertonic saline-AHR associated with 
sensitization to HDMs may be related to seasonal variation in 
EIB.
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